Oslo Science City — university-hospital-industry innovation district

Oslo Science City is Norway's first formally organised innovation district, launched in 2019 to knit together the country's largest concentration of research and clinical capacity: the University of Oslo, Oslo University Hospital (the largest hospital in the Nordic region), the applied-research institute SINTEF, Oslo Cancer Cluster and the City of Oslo. The district spans several campuses from Majorstuen and Blindern to Gaustad and Ullevål, and is organised around four thematic pillars — health and life sciences, climate and environment, digitalisation, and democracy and inclusion.

The initiative works as a shared platform rather than a single building: it convenes researchers, hospital staff, startups, established industry and public-sector partners through working groups, joint events and industrial partnerships, and coordinates major shared infrastructure such as a new 100,000 m² life-science building (due 2026) and expanded Oslo University Hospital facilities (due 2030). More than two-thirds of Norway's medical research is carried out by Oslo Science City members.

As of 2026, the district counts around 7,500-8,000 researchers, 30,000-40,000 students and roughly 300 startup companies, according to Oslo Science City's own figures and independent reporting from Nordic Life Science. The organisers project the fully built district will eventually host some 150,000 researchers, business developers, entrepreneurs and community members. These are participation figures rather than independently measured outcomes — there is not yet published data on jobs created, spin-off revenue or patents resulting from the district's knowledge-transfer activity.

Oslo Science City is a good example of a city co-designing a knowledge-transfer district around existing anchor institutions rather than building one from scratch, and of aligning capital infrastructure (new buildings) with a soft-coordination mandate (working groups, shared branding). The main caveat for other cities is evidential: most published figures are self-reported association counts rather than audited before/after impact data, and the district's flagship infrastructure is still under construction through 2030, so its knowledge-transfer results remain largely prospective.

Read the full analysis: https://nordiclifescience.org/a-district-for-solving-future-challenges/